. 23/06/2021 Understanding how a small molecule compound interacts with its target protein is essential for developing successful drugs. In vitro measurements of ligand affinity and duration of drug-target interactions (e.g., residence time) often do not translate in vivo. Using the NanoBRET™ Target Engagement (TE) method, we will show the impact of oncogenic KRAS (G12C) […]